Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
32544
CAS Number:
69975-86-6
Doxofylline
Purity:
≥ 98 % (HPLC, AT)
Synonym(s):
7-(1,3-dioxolan-2-ylméthyl)-1,3-diméthylpurine-2,6-dione, 7-(1,3-dioxolan-2-ylméthyl)théophylline
Documents
$43.87 /1G
Taille
Request Bulk Quote
Product Information

Bronchodilatateur à base de xanthine qui inhibe l'activité de la phosphodiestérase ! Conserver à l'abri des agents oxydants.

Synonyms
7-(1,3-dioxolan-2-ylméthyl)-1,3-diméthylpurine-2,6-dione, 7-(1,3-dioxolan-2-ylméthyl)théophylline
CAS Number
69975-86-6
Purity
≥ 98 % (HPLC, AT)
Molecular Formula
C11H14N4O4
Molecular Weight
266.25
MDL Number
MFCD00865218
PubChem ID
50942
Melting Point
142 - 146 ?C
Appearance
Poudre cristalline blanche à blanc cassé
Conditions
Conserver entre 2 et 8 °C
General Information
Synonyms
7-(1,3-dioxolan-2-ylméthyl)-1,3-diméthylpurine-2,6-dione, 7-(1,3-dioxolan-2-ylméthyl)théophylline
CAS Number
69975-86-6
Purity
≥ 98 % (HPLC, AT)
Molecular Formula
C11H14N4O4
Molecular Weight
266.25
MDL Number
MFCD00865218
PubChem ID
50942
Melting Point
142 - 146 ?C
Appearance
Poudre cristalline blanche à blanc cassé
Conditions
Conserver entre 2 et 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

Doxofylline is widely utilized in research focused on

  • Respiratory Medicine: It is commonly used as a bronchodilator to treat conditions like asthma and chronic obstructive pulmonary disease (COPD), providing relief by relaxing the airways.
  • Pharmaceutical Formulations: Doxofylline is incorporated into various drug formulations, enhancing the efficacy of respiratory medications and improving patient compliance due to its favorable side effect profile.
  • Clinical Research: Researchers study its pharmacokinetics and pharmacodynamics to optimize dosing regimens and improve therapeutic outcomes in respiratory diseases.
  • Combination Therapies: It is often used in combination with other medications to enhance bronchodilation effects, making it a valuable option for patients with severe symptoms.
  • Patient-Centric Approaches: Doxofylline's unique mechanism of action allows for better management of symptoms with fewer side effects compared to traditional xanthine derivatives, addressing patient concerns effectively.

Citations